BHCFX Mutual Fund

NAV$21.71

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.10%
Dividend Yield (Current)
-
Holdings
41
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Unspecified

Performance

YTD+3.97%
1 Year+23.95%
3 Year+5.42%
5 Year+1.32%

Asset Allocation

Stocks: 100.00%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co9.95%
AZN:LNAstraZeneca PLC5.09%
JNJJohnson & Johnson4.58%
TMOThermo Fisher4.25%
MTDMettler-Toledo International Inc.3.99%
Top 10 Concentration: 43.86%Report Date: Mar 31, 2026
Download all 41 holdings for BHCFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

BHCFX Mutual Fund Overview

BHCFX Mutual Fund (Baron Health Care Fund Retail Class) is managed by Baron Funds. BHCFX expense ratio is 1.10%, holding 41 positions across sectors including Health Care, Unknown, Real Estate. Inception date: 2018-04-30.

BHCFX performance shows a YTD return of 3.97%. The 1-year return is 23.95% and the 5-year return is 1.32%.

BHCFX top holdings include Eli Lilly & Co (9.9%), AstraZeneca PLC (5.1%), Johnson & Johnson (4.6%), Thermo Fisher (4.3%), Mettler-Toledo International Inc. (4.0%). View all BHCFX holdings, sector breakdown, or dividend history.

BHCFX can be compared against other funds using the overlap calculator or side-by-side comparison tool. BHCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.